GeneTx and Ultragenyx Announce First Patient Dosed in Phase 1/2 Clinical Trial of GTX-102 in Patients with Angelman Syndrome March 16, 2020
Blueprint Medicines Announces Part 1 Results from PIONEER Trial Showing Broad Activity of Avapritinib Across Measures of Mast Cell Burden, Clinical Outcomes and Quality of Life in Indolent Systemic Mastocytosis March 16, 2020
Buoy Health Calms Coronavirus Fear, Serves Up Population Health Data to Help Control the Rising Epidemic in the United States March 16, 2020
Acacia Pharma Announces Brief Extension of FDA Review Period for NDA for BYFAVO™, an Ultra-short Acting and Reversible Anesthetic for Procedural Sedation March 12, 2020
Devoted Health recognized by Forbes as one of America’s Best Startup Employers in 2020 March 10, 2020